Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis.

Inclusion Criteria: * Patients of cirrhosis with Hepatocellular carcinoma and portal vein thrombosis * Presence of large oesophageal varices or small with high risk Exclusion Criteria: * Any contra-indication to beta-blockers * Any Endoscopic Variceal Ligation or Sclerotherapy within last 3 months * High risk gastric varices * Any past history of Transhepatic Intrajugular Portosystemic Shunt or surgery for portal hypertension * Significant cardio or pulmonary co-morbidity * Any extrahepatic malignancy * Patients with past history of variceal bleed * Patients with non-tumor portal vein thrombosis * Refusal to participate in the study